東土科技(300353.SZ):擬擇機處置150萬股上海瀚訊股份
格隆匯3月5日丨東土科技(300353.SZ)公佈,截至2020年3月5日,公司持有上海瀚訊(300762.SZ)股份454.5455萬股,該部分股份將於2020年3月16日解除限售。
為提高公司資產流動性及使用效率,公司董事會擬授權管理層根據證券市場情況以及公司經營與財務狀況,在符合相關監管法規的情況下,擇機通過二級市場處置公司持有的150萬股上海瀚訊股份,授權處置期限為本議案經董事會審議通過之日起至2020年12月31日止。
在處置股份期間,如遇上海瀚訊實施轉增股本、紅利送股等事項,則上述處置方案的出售數量將按照除權比例進行相應調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.